Choo Chee Kong

Director, 10% Owner · CytoMed Therapeutics Ltd

Every open-market stock purchase Choo Chee Kong has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.

Total bought
$728.8K
Open-market buys
5
Companies
1
Last buy
Jul 20, 2026

Where the buys stand today

All reported buys

DateTickerSharesPriceValueFiling
Jul 20, 2026100,000$1.50$150.0KSEC ↗
Jul 20, 2026100,000$1.50$150.0KSEC ↗
Jul 14, 2026100,000$1.50$150.0KSEC ↗
Jul 14, 2026100,000$1.50$150.0KSEC ↗
May 13, 2026112,000$1.15$128.8KSEC ↗

Get alerted the next time Choo Chee Kong — or any insider — buys

We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.

About this data

Figures are parsed from Choo Chee Kong's Form 4 filings on SEC EDGAR (CIK 1970632) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.